Study of chemo after stomach cancer surgery
Treatments studied
Part of Cancer, Digestive system clinical trials.
This trial is for people who have already had chemotherapy and surgery for stomach cancer. It compares different follow-up approaches to see if skipping more chemo after surgery is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with stomach cancer that has not spread to distant organs.
- You completed all planned chemotherapy before surgery.
- You had surgery to remove the tumor, and it was within the last 12 weeks.
- Your tumor either completely disappeared after chemo (with no cancer in lymph nodes) or had a very poor response (TRG4-5).
- Your cancer is not HER2-positive or MSI-high type.
- You are in good general health (ECOG 0-1) and your liver and blood counts are adequate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if surgery to remove the stomach and some tumors, after a few months of chemo, helps people whose stomach cancer has spread to only a few nearby spots (like the lining of the belly, liver, or lymph nodes) live longer compared to chemo alone.
This trial studies which surgical approach (removing lymph nodes in a more limited vs more extensive way) works best for gastric cancer after you’ve already started chemotherapy before surgery. It’s aimed at improving cancer control while keeping the operation as safe as possible.
This study looks for ways to predict whether neoadjuvant chemotherapy (chemo given before surgery) will work well in people with locally advanced stomach cancer. It may help doctors choose the best treatment plan sooner based on your test results.
This Phase 3 trial studies whether adding an immune medicine called PD-1 (given as an “inhibitor”) to standard chemotherapy and chemoradiation after stomach/GEJ cancer surgery can lower the risk of cancer coming back. You may qualify if you’ve had surgery removing the tumor and lymph nodes showed higher-risk disease.
This trial tests a combination of chemotherapy drugs given before surgery for locally advanced stomach or gastroesophageal junction cancer. It aims to see if this approach helps shrink the tumor and improve outcomes.
This study compares two chemotherapy plans given before surgery for stage III stomach cancer (or the area where the esophagus meets the stomach). The goal is to see which approach works better to control the cancer and help people get the best surgical outcome.
Hear when a new Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.